HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central Hematocrit Levels in Fetal Malnourished Term Infants.

AbstractBACKROUND:
Fetal malnutrition is especially important for common chronic diseases in adult life. They could potentially be prevented by achieving optimal fetal nutrition.
OBJECTIVE:
The aim of this study was to investigate hematocrit levels of malnourished, term, appropriate for gestational age (AGA) neonates.
SUBJECTS AND METHODS:
A total of 80 AGA neonates (between 10% and 90% percentiles interval according to birth week), born with spontaneous vaginal delivery between 37 and 42 weeks of gestation, detected by both last menstrual period and ultrasonography measurements, were included in the study. Neonates with fetal malnutrition constituted the study group and the control group consisted of well-nourished neonates. We analyzed central venous hematocrit levels obtained 4 hours after birth and maternal risk factors for both groups.
RESULTS:
Although there were no differences in gestational age, head circumference, maternal factors (gravidity, parity, abortions and curettage counts, maternal tobacco use, preeclampsia, hypertension, diabetes mellitus, gestational diabetes mellitus, and history of urinary tract infections), first minute APGAR scores, and sex, Clinical Assessment of Nutritional Status score was lower (29.91±2.87 vs. 21.25±1.65) and hematocrit levels were higher (51.33±2.740 vs. 59.53±5.094) in the fetal malnutrition group (P<0.0001).
CONCLUSIONS:
Central hematocrit levels in malnourished term AGA neonates were found significantly higher than well-nourished term AGA newborns.
AuthorsKerem Ertaş, Özgül Salihoğlu, Emrah Can, Sami Hatipoğlu, Şahin Hamilçikan
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 39 Issue 8 Pg. e426-e429 (11 2017) ISSN: 1536-3678 [Electronic] United States
PMID28538089 (Publication Type: Journal Article)
Topics
  • Adult
  • Apgar Score
  • Body Weights and Measures
  • Female
  • Fetal Nutrition Disorders (blood, diagnosis)
  • Gestational Age
  • Hematocrit
  • Humans
  • Infant, Newborn
  • Male
  • Physical Examination
  • Pregnancy
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: